advertisement

---

Journal of Ocular Pharmacology and Therapeutics 15

Showing records 1 to 15 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Inoue K
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358

---

100284 Effects of Topical Antiglaucomatous Medications on Conjunctival Thickness: A Prospective Anterior Segment Optical Coherence Tomography Study
Kutlutürk G
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 287-293

---

100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Ghosn C
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318

---

100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Shiokawa M
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358

---

100284 Effects of Topical Antiglaucomatous Medications on Conjunctival Thickness: A Prospective Anterior Segment Optical Coherence Tomography Study
Altan C
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 287-293

---

100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Rajagopalan L
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318

---

100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Kunimatsu-Sanuki S
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358

---

100284 Effects of Topical Antiglaucomatous Medications on Conjunctival Thickness: A Prospective Anterior Segment Optical Coherence Tomography Study
Yasar T
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 287-293

---

100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Ugarte S; Mistry S
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318

---

100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Nozaki N
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358

---

100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Orilla W
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318

---

100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Shimizu K
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358

---

100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Goodkin ML
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318

---

100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Ishida K; Tomita G
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358

---

100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Robinson MR; Engles M; Dibas M
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318

---